Skip to main content

Advertisement

Log in

Identification of the immunodominant cytotoxic T-cell epitope of human -1 antitrypsin

  • Letter to the Editor
  • Published:
Gene Therapy Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

References

  1. Song S, Morgan M, Ellis T, Poirier A, Chesnut K, Wang J et al. Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc Natl Acad Sci USA 1998; 95: 14384–14388.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Cerullo V, McCormack W, Seiler M, Mane V, Cela R, Clarke C et al. Antigen-specific tolerance of human alpha1-antitrypsin induced by helper-dependent adenovirus. Hum Gene Ther 2007; 18: 1215–1224.

    Article  CAS  PubMed  Google Scholar 

  3. Kay MA, Graham F, Leland F, Woo SL . Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology 1995; 21: 815–819.

    CAS  PubMed  Google Scholar 

  4. Song S, Embury J, Laipis PJ, Berns KI, Crawford JM, Flotte TR . Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors. Gene Therapy 2001; 8: 1299–1306.

    Article  CAS  PubMed  Google Scholar 

  5. Song S, Scott-Jorgensen M, Wang J, Poirier A, Crawford J, Campbell-Thompson M et al. Intramuscular administration of recombinant adeno-associated virus 2 alpha-1 antitrypsin (rAAV-SERPINA1) vectors in a nonhuman primate model: safety and immunologic aspects. Mol Ther 2002; 6: 329–335.

    Article  CAS  PubMed  Google Scholar 

  6. Koulmanda M, Bhasin M, Hoffman L, Fan Z, Qipo A, Shi H et al. Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc Natl Acad Sci USA 2008; 105: 16242–16247.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Lewis EC, Mizrahi M, Toledano M, Defelice N, Wright JL, Churg A et al. {alpha}1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc Natl Acad Sci USA 2008; 105: 16236–16241.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Brantly ML, Spencer LT, Humphries M, Conlon TJ, Spencer CT, Poirier A et al. Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults. Hum Gene Ther 2006; 17: 1177–1186.

    Article  CAS  PubMed  Google Scholar 

  9. Parker KC, Bednarek MA, Coligan JE . Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994; 152: 163–175.

    CAS  PubMed  Google Scholar 

  10. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S . SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999; 50: 213–219.

    Article  CAS  PubMed  Google Scholar 

  11. Gao GP, Yang Y, Wilson JM . Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J Virol 1996; 70: 8934–8943.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J M Wilson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Breous, E., Somanathan, S. & Wilson, J. Identification of the immunodominant cytotoxic T-cell epitope of human -1 antitrypsin. Gene Ther 16, 1380–1382 (2009). https://doi.org/10.1038/gt.2009.100

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2009.100

  • Springer Nature Limited

This article is cited by

Navigation